BeOne Medicines Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
246.66
-6.12 (-2.42%)
At close: Jun 20, 2025, 4:00 PM
247.08
+0.42 (0.17%)
After-hours: Jun 20, 2025, 4:11 PM EDT
BeOne Medicines Employees
BeOne Medicines had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$379,624
Profits / Employee
-$35,670
Market Cap
29.32B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ONC News
- 4 days ago - BeOne Medicines: Brukinsa Momentum And Pipeline Catalysts Justify Its Premium - Seeking Alpha
- 8 days ago - BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025 - Business Wire
- 9 days ago - U.S. FDA Approves Tablet Formulation of BeOne's BRUKINSA® for All Approved Indications - Business Wire
- 9 days ago - BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 - Business Wire
- 16 days ago - BeOne Medicines: Competitive Advantage Of Zanubrutinib In The CLL Field - Seeking Alpha
- 18 days ago - BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025 - Business Wire
- 20 days ago - BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025 - Business Wire
- 24 days ago - BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology - Business Wire